Status:
COMPLETED
Effect of Estradiol Pretreatment on Antagonist ICSI Cycles
Lead Sponsor:
Alexandria University
Conditions:
Female Infertility
Eligibility:
FEMALE
20-37 years
Phase:
PHASE4
Brief Summary
Depended on the hypothesis that growth asynchrony of antral follicles is a consequence of the gradual follicle stimulating hormone (FSH) elevation that occurs during the late luteal phase, the aim of ...
Detailed Description
Gonadotropin-releasing hormone antagonist (GnRH-ant) cycles are characterized by higher patient acceptability with more attention being directed to the potential effect of steroid pretreatment to prog...
Eligibility Criteria
Inclusion
- Women age 20-37 years.
- Anti-mullerian (AMH) level greater than 1.2 ng/ml.
- Body mass index between 18 and 29 kg/m2.
- Undergoing a first or second ICSI cycles.
Exclusion
- Endometriosis.
- Uterine disorders such as fibroids and uterine anomalies.
- Antral follicular counts (AFC) less than 10.
- Azoospermic males.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2021
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT05197374
Start Date
June 1 2020
End Date
November 15 2021
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVF center
Alexandria, Egypt